Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.58 USD | -3.00% | +4.18% | -37.33% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.33% | 817M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.84% | 22.02B | |
-17.84% | 20.9B | |
-9.19% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Rating